Cargando…

Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy

COVID-19, the syndrome caused by the infection with SARS-CoV-2 coronavirus, is characterized, in its severe form, by interstitial diffuse pneumonitis and acute respiratory distress syndrome (ARDS). ARDS and systemic manifestations of COVID-19 are mainly due to an exaggerated immune response triggere...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iovino, Lorenzo, Thur, Laurel A, Gnjatic, Sacha, Chapuis, Aude, Milano, Filippo, Hill, Joshua A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126446/ https://www.ncbi.nlm.nih.gov/pubmed/33986127 http://dx.doi.org/10.1136/jitc-2021-002392

Ejemplares similares

Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy
por: Tsuji, Takemasa, et al.
Publicado: (2012)

Pain Management in Childhood Leukemia: Diagnosis and Available Analgesic Treatments
por: Coluzzi, Flaminia, et al.
Publicado: (2020)

Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILs
por: Alabanza, Leah, et al.
Publicado: (2014)

The Role of Microglia in Bacterial Meningitis: Inflammatory Response, Experimental Models and New Neuroprotective Therapeutic Strategies
por: Thorsdottir, Sigrun, et al.
Publicado: (2019)

Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I—conceptual challenges
por: Rutella, Sergio, et al.
Publicado: (2020)

Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II—practical challenges
por: Cesano, Alessandra, et al.
Publicado: (2020)

Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
por: Chapuis, Nicolas, et al.
Publicado: (2019)

Infusion of Non-HLA-Matched Off-the-Shelf Ex Vivo Expanded Cord Blood Progenitors in Patients Undergoing Cord Blood Transplantation: Result of a Phase II Clinical Trial
por: Milano, F., et al.
Publicado: (2022)

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2021)

Intervention strategies for microbial therapeutics in cancer immunotherapy
por: Gopalakrishnan, V., et al.
Publicado: (2020)

Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipients
por: Lopedote, Paolo, et al.
Publicado: (2023)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, December 5(th) 2015
por: Ascierto, Paolo A., et al.
Publicado: (2016)

COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges
por: Popa, Iolanda Valentina, et al.
Publicado: (2020)

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
por: Wong, Serre-Yu, et al.
Publicado: (2021)

Microbiome-based interventions: therapeutic strategies in cancer immunotherapy
por: Soto Chervin, C., et al.
Publicado: (2020)

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
por: Grignano, Eric, et al.
Publicado: (2020)

Cord Blood Maternal Microchimerism Following Unrelated Cord Blood Transplantation
por: Kanaan, Sami B., et al.
Publicado: (2020)

Effects of Alcohol on the Cardiovascular System in Women
por: Piano, Mariann R., et al.
Publicado: (2020)

Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
por: Germain, Claire, et al.
Publicado: (2015)

Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy
por: Wang, Shixiang, et al.
Publicado: (2019)

Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
por: Lu, Yuting, et al.
Publicado: (2022)

Immunotherapy biomarkers 2016: overcoming the barriers
por: Gulley, James L., et al.
Publicado: (2017)

Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19
por: Qin, Zhen, et al.
Publicado: (2021)

COVID-19: Brief overview of therapeutic strategies
por: Beaumont, Anne-Lise, et al.
Publicado: (2023)

Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy
por: Koch, Regina M., et al.
Publicado: (2021)

Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy
por: Sampath, Padma, et al.
Publicado: (2015)

Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
por: Li, Bolei, et al.
Publicado: (2021)

An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy
por: Zaher, Amira, et al.
Publicado: (2022)

Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
por: Hou, Wanting, et al.
Publicado: (2022)

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
por: Maes, Michael, et al.
Publicado: (2012)

Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections
por: Cavalli, Carolina Aliai Micol, et al.
Publicado: (2023)

510. Elevated IL-1β level as a predictor of inflammation and death in COVID-19
por: Swartz, Talia H, et al.
Publicado: (2020)

Innovative information-sharing strategies.
por: Kay, B A, et al.
Publicado: (1998)

Role of inflammatory response in liver diseases: Therapeutic strategies
por: Del Campo, José A, et al.
Publicado: (2018)

Cancer immunotherapy strategies that target the cGAS-STING pathway
por: Tian, Zhuoying, et al.
Publicado: (2022)

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
por: Gnjatic, Sacha, et al.
Publicado: (2017)

P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
por: Liang, Emily, et al.
Publicado: (2023)

Is immunotherapy in the future of therapeutic management of sarcomas?
por: Clemente, Ottavia, et al.
Publicado: (2021)

Manipulation of the inflammatory reflex as a therapeutic strategy
por: Kelly, Mark J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f6o0ldor5s90rm7ecspuqo07ir